BioSpace News Archive

Business

Aquestive Therapeutics Provides End of Year Business Update, Including Progress of its Proprietary CNS Assets, Financial and Legal Matters

Projects full year 2018 revenues over $67 million, exceeding expectations, and projects end-of-year cash and cash equivalents in the range of $58 million to $60 million

December 20, 2018
·
13 min read
Deals

Encision Completes Private Placement of Common Stock

Encision Inc. today announced that it had completed a private placement of 875,000 shares of its common stock to CMED Partners LLLP (“CMED”).

December 20, 2018
·
2 min read
Policy

Cepheid Receives CE-IVD Clearance for Xpert® HBV Viral Load

Simplify Hepatitis B Treatment Management

December 20, 2018
·
2 min read
Genetown

Relay Therapeutics Secures $400 Million in Series C Financing

Proceeds to Support Scaling and Advancement of Therapeutics Pipeline & Enhancement of Computational and Experimental Platform

December 20, 2018
·
3 min read
Biotech Beach

MassRoots Preparing Launch of CBD Product-Focused Review and E-Commerce Platform

Aims to be a leading information portal for millions of consumers interested in CBD products; exploring E-Commerce for hemp-derived CBD products following passage of the Farm Bill

December 20, 2018
·
3 min read
Job Trends

The Growth of Non-Industrial Robotics Is Driving a Diversification of New Robotics Applications, According to Tractica

More than 100 Discrete Use Cases Are Fueling Market Growth in Enterprise, Consumer, Government, and Military Robots

December 20, 2018
·
2 min read
Business

Walgreens Boots Alliance Reports Fiscal 2019 First Quarter Results

Delivers Double Digit Percentage Growth in Earnings Per Share (EPS)

December 20, 2018
·
31 min read
Business

Gilead And Agenus Enter into Collaboration to Develop Immuno-Oncology Therapies

-- Agenus Webcast and Conference Call Scheduled for Today at 8:30a.m.ET --

December 20, 2018
·
6 min read
Mylan to Present at the 37th Annual J.P. Morgan Healthcare Conference

Mylan N.V. today announced that CEO Heather Bresch will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, Calif., on Tuesday, Jan. 8, 2019, at 11 a.m. PT / 2 p.m. ET.

December 20, 2018
·
1 min read
Policy

Merck KGaA, Darmstadt, Germany, Assigns Chimeric Antigen Receptor T-cell (CAR-T) Rights to Intrexon

Agreement enables Merck KGaA, Darmstadt, Germany, to maintain an investment in the rapidly advancing oncology field of CAR-T, while focusing its R&D efforts

December 20, 2018
·
4 min read